Released: 08/04/2023 Expires: 07/31/2024 (subject to change)
CE for this activity will not be available after this date.
This activity includes closed captioning.
Delivery Note: The content for this activity was previously presented during the 2023 AANP National Conference. If you already completed the content of this activity while attending the live or virtual conference, you should not complete this content a second time. Learners should only complete ONE delivery-method to earn credit. Completing multiple delivery options for the same activity is considered duplicate credit for the same content and will not be accepted by regulatory bodies.
Pneumococcal disease is the second most common cause of vaccine-preventable disease. Pneumococcal vaccination recommendations have been updated frequently over the years, and it is imperative that nurse practitioners stay updated on the new guidelines. Join NP experts Ruth Carrico and Mary Koslap-Petraco as they provide an overview of pneumococcal disease, discuss recommendations for pneumococcal vaccination and identify strategies for overcoming barriers to vaccination.
Summarize the CDC recommendations regarding pneumococcal vaccination across the lifespan.
Evaluate candidates for pneumococcal vaccination and identify the appropriate vaccine that they should receive.
Recognize the importance of reviewing the vaccination history at every encounter across all age groups.
Identify strategies to help ameliorate the impact that racial disparities, social determinants of health, vaccine hesitancy and provider biases have on the utilization and uptake of pneumococcal vaccination.
Speakers Dr. Ruth Carrico PhD DNP APRN FNP-C CIC FSHEA FNAP FAAN Dr. Mary Koslap-Petraco, DNP PPCNP-BC CPNP FAANP Disclosure This program was planned in accordance with AANP CE Standards and Policies.
The speakers have the following disclosures:
Speaker has no relevant financial relationships to disclose.
Advisory Boards—Pfizer (COVID-19, Meningococcal), Moderna (COVID-19), Seqirus (Influenza), Novavax (COVID-19)
Research—Sanofi-Pasteur (Yellow Fever), Pfizer (RSV), Janssen/Johnson & Johnson (COVID-19)
All Planners involved in this activity have no relevant financial relationships to disclose.
This activity is supported by an independent educational grant from Merck & Co., Inc. This presentation was first released as a Live/Hybrid event at AANPs 2023 National Conference in New Orleans.
Disclaimer Individuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program. CE Credit Instructions
Read this activity description, including objectives and disclosures.
Complete the Pretest associated to the activity.
Complete the educational content:
Video Presentations: Click the Play button to watch the activity presentation. Full participation credit for the activity will be received once the entire video has been watched.
Click on the Additional Resources button to review all additional materials provided (handouts, post-test reviews, any other downloadable resources).
After completing all content, click on the blue Next Steps button:
Complete the post-test.
Submit the evaluation to receive full AANP CE/Rx credit.
Additional Information For questions or more information concerning this online CE opportunity contact the AANP CE Center Manager at CECenter@aanp.org.
1 Contact Hour(s) of CE, 0.5 of which may be applied towards Pharmacology